Puma Biotechnology Files 8-K on Shareholder Vote Matters
Ticker: PBYI · Form: 8-K · Filed: Jun 13, 2025 · CIK: 1401667
| Field | Detail |
|---|---|
| Company | Puma Biotechnology, Inc. (PBYI) |
| Form Type | 8-K |
| Filed Date | Jun 13, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, filing
Related Tickers: PBYI
TL;DR
Puma Biotech held a shareholder vote on June 11th. Details filed today.
AI Summary
Puma Biotechnology, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of its security holders on June 11, 2025. The filing details the company's corporate structure and its principal executive offices located at 10880 Wilshire Boulevard, Suite 2150, Los Angeles, California.
Why It Matters
This filing indicates that Puma Biotechnology held a shareholder vote, which could pertain to significant corporate decisions or governance changes that may impact investors.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- PUMA BIOTECHNOLOGY, INC. (company) — Registrant
- June 11, 2025 (date) — Date of earliest event reported
- June 13, 2025 (date) — Date of report
- 10880 Wilshire Boulevard, Suite 2150 Los Angeles, California 90024 (address) — Principal executive offices
- INNOVATIVE ACQUISITIONS CORP (company) — Former company name
FAQ
What specific matters were submitted to a vote of Puma Biotechnology's security holders on June 11, 2025?
The filing states that matters were submitted to a vote of security holders on June 11, 2025, but does not specify the exact nature of these matters within the provided text.
When was the report filed with the SEC?
The report was filed as of June 13, 2025.
What is Puma Biotechnology, Inc.'s principal executive office address?
The principal executive offices are located at 10880 Wilshire Boulevard, Suite 2150, Los Angeles, California 90024.
What is the company's state of incorporation?
The company is incorporated in Delaware.
Has the company operated under a different name previously?
Yes, the company was formerly known as INNOVATIVE ACQUISITIONS CORP, with a date of name change on June 1, 2007.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding PUMA BIOTECHNOLOGY, INC. (PBYI).